<?xml version="1.0" encoding="UTF-8" standalone="yes"?><trialResultsOutput hits="1" offset="0" totalResults="1"><Filters total="48"><Filter label="Trial Technologies" name="trialTechnologies" total="0"/><Filter label="Indications" name="indications" total="1"><FilterOption id="837" count="1" label="Non-insulin dependent diabetes"/></Filter><Filter label="Endpoint Index" name="trialEndpointIndex" total="0"/><Filter label="Trial Drug Phase Highest" name="trialDrugPhaseHighest" total="0"/><Filter label="Trial Company Sponsor" name="trialCompaniesSponsor" total="1"><FilterOption id="1037367" count="1" label="National University Of Ireland Maynooth"/></Filter><Filter label="Trial Recruitment Status" name="trialRecruitmentStatus" total="1"><FilterOption id="12" count="1" label="Status not specified"/></Filter><Filter label="Trial Commercially Significant" name="trialIsCommerciallySignificant" total="1"><FilterOption id="NO" count="1" label="No"/></Filter><Filter label="Trial Indications Pioneer" name="trialIndicationsPioneer" total="0"/><Filter label="Registry Id" name="trialRegistries" total="0"/><Filter label="Trial Reason for Discontinuation" name="trialReasonForDiscontinuation" total="0"/><Filter label="Active Controls" name="trialActiveControls" total="0"/><Filter label="Exclusion Criteria Index" name="trialExclusionCriteriaIndex" total="0"/><Filter label="Trial Date Enrollment End By Month" name="trialDateEnrollmentEndByMonth" total="0"/><Filter label="Funder Type" name="trialFunderType" total="1"><FilterOption id="ACA" count="1" label="Academic"/></Filter><Filter label="Trial Region" name="trialRegions" total="0"/><Filter label="Patient Segment Index" name="trialPatientSegmentIndex" total="0"/><Filter label="Primary Completion Filter by Month" name="trialPrimaryCompletionDateByMonth" total="0"/><Filter label="Trial Country" name="trialCountries" total="0"/><Filter label="Trial Patient Selection" name="trialTermsPatientSelection" total="1"><FilterOption id="EVHVA" count="1" label="Healthy volunteers accepted"/></Filter><Filter label="Trial Terms Design" name="trialTermsDesign" total="2"><FilterOption id="SOSCOH" count="1" label="Cohort"/><FilterOption id="SSTOBS" count="1" label="Observational"/></Filter><Filter label="Trial Source" name="trialSources" total="1"><FilterOption id="OTHERS" count="1" label="Others only"/></Filter><Filter label="Trial Actions Secondary Interventions Primary" name="trialActionsSecondaryInterventionsPrimary" total="0"/><Filter label="Trial Endpoint Achieved" name="trialEndpointsAchieved" total="1"><FilterOption id="UNSPECIFIED" count="1" label="Unspecified"/></Filter><Filter label="Endpoint Index Secondary" name="trialEndpointIndexSecondary" total="0"/><Filter label="Biomarker" name="trialBiomarkerNames" total="5"><FilterOption id="172" count="1" label="Adiponectin"/><FilterOption id="289" count="1" label="Hemoglobin A, glycosylated"/><FilterOption id="176" count="1" label="Interleukin-6"/><FilterOption id="3274" count="1" label="Scavenger receptor cysteine-rich type 1 protein M130"/><FilterOption id="274" count="1" label="Tumor necrosis factor"/></Filter><Filter label="Trial Terms Endpoint" name="trialTermsEndpoint" total="0"/><Filter label="Trial Interventions Primary In Regimen Name Display" name="trialInterventionsPrimaryInRegimenNameDisplay" total="0"/><Filter label="Trial Document Source" name="trialDocumentSource" total="1"><FilterOption id="OTHER" count="1" label="Other Publications"/></Filter><Filter label="Trial Interventions Primary Alone Name Display" name="trialInterventionsPrimaryAloneNameDisplay" total="0"/><Filter label="Trial Interventions Control In Regimen Name Display" name="trialInterventionsControlInRegimenNameDisplay" total="0"/><Filter label="Trial Category" name="trialCategory" total="1"><FilterOption id="9" count="1" label="Medical procedure"/></Filter><Filter label="Trial Outcome Available" name="trialOutcomesAvailable" total="1"><FilterOption id="YES" count="1" label="Yes"/></Filter><Filter label="Trial Actions Primary Interventions Primary" name="trialActionsPrimaryInterventionsPrimary" total="0"/><Filter label="Trial Company Collaborator" name="trialCompaniesCollaborator" total="0"/><Filter label="Trial Actions Secondary Interventions Control" name="trialActionsSecondaryInterventionsControl" total="0"/><Filter label="Biomarker Type" name="trialBiomarkerTypes" total="3"><FilterOption id="32" count="1" label="Biochemical"/><FilterOption id="38" count="1" label="Genomic"/><FilterOption id="37" count="1" label="Proteomic"/></Filter><Filter label="Biomarker Role" name="trialBiomarkerRoles" total="1"><FilterOption id="695863716" count="1" label="Therapeutic effect marker"/></Filter><Filter label="Interventions" name="trialInterventions" total="0"/><Filter label="Endpoint Index Primary" name="trialEndpointIndexPrimary" total="0"/><Filter label="Sponsors/Collaborators" name="trialCompanies" total="1"><FilterOption id="1037367" count="1" label="National University Of Ireland Maynooth"/></Filter><Filter label="Last Changed Date By Day" name="trialDateChangeLastByDay" total="1"><FilterOption count="1" label="2017-01-04"/></Filter><Filter label="Trial Date End By Month" name="trialDateEndByMonth" total="0"/><Filter label="Trial Date Start By Month" name="trialDateStartByMonth" total="0"/><Filter label="Trial Phase" name="trialPhase" total="1"><FilterOption id="PNA" count="1" label="Phase Not Applicable"/></Filter><Filter label="Inclusion Criteria Index" name="trialInclusionCriteriaIndex" total="0"/><Filter label="Trial Interventions Control Alone Name Display" name="trialInterventionsControlAloneNameDisplay" total="0"/><Filter label="Trial Actions Primary Interventions Control" name="trialActionsPrimaryInterventionsControl" total="0"/><Filter label="Trial Indications Adverse" name="trialIndicationsAdverse" total="0"/></Filters><SearchResults><Trial Id="146554"><Indications><Indication>Non-insulin dependent diabetes</Indication></Indications><CompaniesSponsor><Company>National University Of Ireland Maynooth</Company></CompaniesSponsor><DateChangeLast>2017-01-04T00:00:00Z</DateChangeLast><InterventionsPrimaryDisplay><Intervention>GLP-1 analogue therapy alone</Intervention></InterventionsPrimaryDisplay><Phase>Phase Not Applicable</Phase><RecruitmentStatus>Status not specified</RecruitmentStatus><Teaser>The aim of this cohort study was to assess the hypothesis that glucagon-like peptide 1 (GLP-1) analogue therapy would positively impact on inflammation and macrophage polarization in obese type 2 diabetes mellitus (T2DM) patients [ 1437009 ].</Teaser><TrialCategories><Category>Medical procedure</Category></TrialCategories><TermsDesign><Term>Observational</Term><Term>Cohort</Term></TermsDesign><TermsPatientSelection><Term>Healthy volunteers accepted</Term></TermsPatientSelection><TitleDisplay>A cohort study to assess the hypothesis that glucagon-like peptide 1 (GLP-1) therapy would positively impact on inflammation and macrophage polarization in obese type 2 diabetes mellitus (T2DM) patients</TitleDisplay><BiomarkerNames><BiomarkerName>Adiponectin </BiomarkerName><BiomarkerName> Hemoglobin A, glycosylated </BiomarkerName><BiomarkerName> Interleukin-6 </BiomarkerName><BiomarkerName> Scavenger receptor cysteine-rich type 1 protein M130 </BiomarkerName><BiomarkerName> Tumor necrosis factor</BiomarkerName></BiomarkerNames><PrimaryCompletionDate/><NumberOfSites>0</NumberOfSites></Trial></SearchResults></trialResultsOutput>